You are here

  • Home
  • Archive
  • Volume 16, Issue 1
  • The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin™) in chemoresistant ovarian cancer cells

Citation Tools

Article menu
Download PDFPDF
Original Articles
The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin™) in chemoresistant ovarian cancer cells

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Menendez JA, Vellon L, Lupu R
The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin™) in chemoresistant ovarian cancer cells
International Journal of Gynecologic Cancer 2006;16:219-221.